PRME

Prime Medicine, Inc. - Common Stock (PRME)

About Prime Medicine, Inc. - Common Stock (PRME)

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Details

Daily high

$3.22

Daily low

$3.00

Price at open

$3.18

52 Week High

$6.94

52 Week Low

$2.67

Market cap

576.8M

Dividend yield

Volume

2.6M

Avg. volume

2.8M

P/E ratio

-2.93

Prime Medicine, Inc. - Common Stock News